CN106381284A - Method for preparing stem cell active factor - Google Patents
Method for preparing stem cell active factor Download PDFInfo
- Publication number
- CN106381284A CN106381284A CN201610819087.4A CN201610819087A CN106381284A CN 106381284 A CN106381284 A CN 106381284A CN 201610819087 A CN201610819087 A CN 201610819087A CN 106381284 A CN106381284 A CN 106381284A
- Authority
- CN
- China
- Prior art keywords
- cell
- stem cell
- activity factor
- culture
- lyophilization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Water Supply & Treatment (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a method for preparing a stem cell active factor, and on one hand, in particular relates to a method for preparing the stem cell active factor. The method comprises the following steps of: (1) acquiring umbilical cord placenta derived mesenchymal stem cells; (2) performing cell amplification; (3) performing cell identification detection; (4) preparing the stem cell active factor; and (5) performing optional freeze-drying. Furthermore, the invention relates to a stem cell active factor freeze-dried powder agent prepared by using the method demonstratively. The method provided by the invention has the beneficial effects as shown in the specification of the invention.
Description
Technical field
The invention belongs to stem cells technology field is and in particular to a kind of people source mescenchymal stem cell factor and preparation method thereof
And purposes, more particularly to a kind of method preparing the Stem Cell Activity factor by umbilical cord mesenchymal stem cells.The inventive method energy
Enough the Stem Cell Activity factor is prepared with efficient, stable performance.
Background technology
In recent years, with deepening continuously that mescenchymal stem cell is studied, its excreted factor has become the heat of researchers
Point.Mescenchymal stem cell can secrete multiple cytokines with biological activity, and these cytokines can regulate and control machine effectively
Somatic cell signal transduction, activating human body stem cell, and then physiological reparation or the cell substituting body injury, pathological changes and aging.
Application in beauty treatment for the stem cell, is utilization in plastic surgery for the stem cell earliest, and it is that current research is more
A kind of stem cell beautifying technique.And the stem cell species applying more in plastic surgery is also mainly human umbilical cord mesenchymal
Stem cell, human adipose mesenchymal stem cells etc..
Traditionally so-called stem cell cosmesiss, typically all direct injection stem cell injection.And this injection do thin
The source of born of the same parents is mainly extracted from the embryo of miscarriage, so can cause immunological rejection unavoidably, and exists certain
Reason problem.Even with autologous stem cells, such as human adipose mesenchymal stem cells, but the culture amplification procedure in stem cell
In also can introduce ectogenic albumen (hyclone) unavoidably, easily cause immunological rejection.So, scientists carry recently
Go out a kind of new stem cell application process, the application of cells and supernatant active factorses and cell pyrolysis liquid.
Cytokine is added to cosmetics, the moisturizing white-skinned face function not only with general cosmetics is additionally it is possible to repair
Multiple damaged skin, eliminates wrinkle of skin, pore refining, improves complexion etc., increasingly paid close attention to by people.
The cosmetics of factor-containing list in multiple countries, especially with the prosperity the most of beauty and shaping industry
Korea S, cytokine cosmetics are particularly very capable.The stem cell company that China also has many families larger have developed cytokine
Cosmetics.But cytokine cosmetics on the market are mixed after being typically directly incorporated into using stem cell culture supernatant or being freeze-dried
The mode of cosmetic base manufactures, and cytokine content is relatively low, and containing other impurity such as a large amount of sugars, using these cosmetics
The senses of discomfort such as xerosis cutiss can be caused afterwards on the contrary.
Research shows that cell culture supernatant contains the various cytokines with biological activity, and its application can avoid
The immunological rejection of generation during stem cell beauty treatment.But, the culture supernatant of liquid is short in the room temperature holding time, and this just hinders
Its promotion and application.
In addition, being directed to current stem cell sorting technology, the relatively common magnetic bead sorting being, but in the sorting of routine, magnetic
Pearl can together carry out follow-up culture in company with stem cell, and that is, magnetic bead does not separate from stem cell, so for dry thin
The later stage of born of the same parents produces, and inherently producing certain impact although there being certain methods, such as adding some bacterium or other materials to carry out
Degraded, but so also correspond to add the compositions such as other exogenous proteins, cause the secondary pollution to stem cell, thus real
Do not solve the above problems on border.
Also there are some to carry out the report of extraction purification to stem cell culture supernatant at present, but effect is not still good, for example
Notification number is that the patent of CN102600057B discloses a kind of preparation method of human placenta stem cell extract freeze-drying powder, to obtaining
Cell culture fluid ultrafiltration retention is carried out using single 3000D filter membrane, it eliminates partial impurities, but the impurity such as saccharide is still
Do not remove, and also result in cytokine and lose in a large number, repairing effect is not good, and equally will also result in the discomforts such as xerosis cutiss
Sense, actual application value is relatively low.
Additionally, current people are also difficult to produce the Stem Cell Activity factor with efficient and/or stable performance.
Content of the invention
Present invention aim at providing a kind of side to produce the Stem Cell Activity factor with efficient and/or stable performance
Method.Have now surprisingly been found that, the beneficial effect that can realize the one or more aspect of the present invention using the inventive method is simultaneously
Produce the Stem Cell Activity factor.The present invention is based on this and finds and be accomplished.
For this reason, first aspect present invention provides a kind of method preparing the Stem Cell Activity factor, it comprises the following steps：
(1) Mesenchymal Stem Cells from Umbilical Cord obtains：
Take health full term Cesarean esction anemia of pregnant woman's umbilical cord, by separating magnificent Tong Shi glue (Wharton's Jelly) method, logical using China
Prepared by family name's colloidal suspension method；Magnificent Tong Shi glue is put in T75 culture bottle, adds appropriate mescenchymal stem cell (MSC) serum-free medium,
It is placed in 37 DEG C, culture in 5% CO2 incubator, cell colony in 7 days later in culture；Cell reaches saturation within about 10-13 days,
Can be passed on；Cell is in spindle shape, is typical fibroblast sample form；
(2) cell amplification：
When cell fusion degree reaches 70-80%, gently rinse culture bottle cell 1-2 time with normal saline, add 3-5ml and disappear
Change liquid, room temperature places 1-2 minute, Microscopic observation cell subglobular, gently pats bottle wall, stops digestion, is transferred to centrifuge tube
Mix, sampling counts, according to 8000 cell/cm2Passed on, when cell density reaches 70-80% within 2-3 days, above behaviour repeatedly
Make, to obtain the MSC of q.s, typically adopt P3-P5 to prepare for cell；
(3) cellular identification detection：
When Cell viability reaches more than 90%, flow cytometer detection mark is qualified；
(4) preparation of the Stem Cell Activity factor：
4i) cell culture to the most vigorous when, collect supernatant to centrifuge tube, 0.22 μm of membrane filtration supernatant is degerming；
4ii) clean 2-3 culture bottle with normal saline, discard, then adopt cell starvation method to add 10ml physiology salt
Water/T225 culture bottle continues culture 12-24 hour, treats cell rounding, and piping and druming moves to centrifuge tube, using Ultrasonic Cell Disruptor after mixing
Centrifugation 1400rpm after smudge cellses, centrifugation 5min, the supernatant of collection, degerming through 0.22 μm of membrane filtration；
4iii) by step 4i) and supernatant mixing 4ii), dense using the purification ultrafiltration system for 10KD for the molecular cut off
Contracting, obtains final product Stem Cell Activity factor concentrated solution.
The method of any embodiment according to a first aspect of the present invention, wherein described in step (2), Digestive system is 0.25%
Pancreatin.
The method of any embodiment according to a first aspect of the present invention, flow cytometer detection mark wherein described in step (3)
For：CD73, CD90, CD105 expression is positive, and HLA-DR, CD11b, CD19, CD34, CD45 expression is negative.
The method of any embodiment according to a first aspect of the present invention, flow cytometer detection mark wherein described in step (3)
Show in result that cell has into fat, skeletonization, becomes cartilage differentiation potential.
The method of any embodiment according to a first aspect of the present invention, the wherein 4i of step (4)) in cell culture to the most prosperous
Flower refers to cell fusion degree about 70-80%.
The method of any embodiment according to a first aspect of the present invention, the wherein 4ii of step (4)) in adopt ultrasonication
During instrument smudge cellses, its program is：4 DEG C, 500w, ultrasonic 2 seconds, it is spaced 8 seconds, 86 circulations.
The method of any embodiment according to a first aspect of the present invention, it still further comprises step (5), that is, to step
(4) the gained Stem Cell Activity factor carries out cryodesiccated step.
The method of any embodiment according to a first aspect of the present invention, wherein said freezes to the Stem Cell Activity factor
The step that (in order to long-term preserve) is dried includes operating as follows：
5i) in step (4) gained Stem Cell Activity factor concentrated solution, add freeze drying protectant, be dispensed in cillin bottle,
Partly jump a queue, put in freezer dryer；
5ii) open freezer dryer, by predetermined lyophilization program, sample is carried out with lyophilization, tamponade seals, and obtains final product
Freeze dried powder.
It is in generally loose porous organization by this lyophilization obtained freeze-drying powder, and can protect for a long time at room temperature
Deposit.
The method of any embodiment according to a first aspect of the present invention, the wherein 5i of step (5)) described in freeze drying protectant
Selected from trehalose, Mannitol, shitosan, dextran, glycine, arginine, glycine.
The method of any embodiment according to a first aspect of the present invention, the wherein 5i of step (5)) described in freeze drying protectant
Concentration in described concentrated solution is 0.5%～10%, particularly 1%～6%.
The method of any embodiment according to a first aspect of the present invention, the wherein 5i of step (5)) described in subpackage be with
Described Stem Cell Activity factor concentrated solution is added in described cillin bottle the amount that 3ml/ props up.
The method of any embodiment according to a first aspect of the present invention, the wherein 5ii of step (5)) described in lyophilization
Program includes following operation sequence：
Precooling：Precooling 3.5h (precooling temperature is usually -30～-40 DEG C) at ambient pressure；
Lyophilization a：Opening vacuum pump and making vacuum degree is 0.014mbar, freezes 2h at a temperature of -38～-40 DEG C；
Lyophilization b：Maintain vacuum constant, be warming up to -20～-25 DEG C, continue lyophilization 12h with this understanding；
Then it is warming up to -2～2 DEG C, continue with this understanding 2h is dried；
Parsing-desiccation：Maintain vacuum constant, be warming up to 33～37 DEG C, continue with this understanding 2-5h is dried.
The method of any embodiment according to a first aspect of the present invention, it still further comprises step (6), that is, to step
(4) gained Stem Cell Activity factor concentrated solution or step (5) gained Stem Cell Activity factor freeze dried powder carry out stem cell work
The operation of sex factor detection, specific as follows：
Take Stem Cell Activity factor concentrated solution 3ml, or lyophilizing front volume is the Stem Cell Activity factor freeze dried powder of 3ml
With 3ml solvent (solvent can be ultra-pure water or hyaluronic acid solution) dilution, using the restructuring coated enzyme linked immunological of personnel's antibody
Test kit (for example, the present invention also adopts, the commercial kit that R＆D company provides) measures the content of the Stem Cell Activity factor.
Further, second aspect present invention provides a kind of Stem Cell Activity factor freeze dried powder, including stem cell
Active factorses and freeze drying protectant.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, wherein said lyophilizing is protected
Shield agent is selected from trehalose, Mannitol, shitosan, dextran, glycine, arginine, glycine.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, it is substantially according to bag
Include what the method for following steps prepared：
(1) Mesenchymal Stem Cells from Umbilical Cord obtains：
Take health full term Cesarean esction anemia of pregnant woman's umbilical cord, by separating magnificent Tong Shi glue (Wharton's Jelly) method, logical using China
Prepared by family name's colloidal suspension method；Magnificent Tong Shi glue is put in T75 culture bottle, adds appropriate mescenchymal stem cell (MSC) serum-free medium,
It is placed in 37 DEG C, culture in 5% CO2 incubator, cell colony in 7 days later in culture；Cell reaches saturation within about 10-13 days,
Can be passed on；Cell is in spindle shape, is typical fibroblast sample form；
(2) cell amplification：
When cell fusion degree reaches 70-80%, gently rinse culture bottle cell 1-2 time with normal saline, add 3-5ml and disappear
Change liquid, room temperature places 1-2 minute, Microscopic observation cell subglobular, gently pats bottle wall, stops digestion, is transferred to centrifuge tube
Mix, sampling counts, according to 8000 cell/cm2Passed on, when cell density reaches 70-80% within 2-3 days, above behaviour repeatedly
Make, to obtain the MSC of q.s, typically adopt P3-P5 to prepare for cell；
(3) cellular identification detection：
When Cell viability reaches more than 90%, flow cytometer detection mark is qualified；
(4) preparation of the Stem Cell Activity factor：
4i) cell culture to the most vigorous when, collect supernatant to centrifuge tube, 0.22 μm of membrane filtration supernatant is degerming；
4ii) clean 2-3 culture bottle with normal saline, discard, then adopt cell starvation method to add 10ml physiology salt
Water/T225 culture bottle continues culture 12-24 hour, treats cell rounding, and piping and druming moves to centrifuge tube, using Ultrasonic Cell Disruptor after mixing
Centrifugation 1400rpm after smudge cellses, centrifugation 5min, the supernatant of collection, degerming through 0.22 μm of membrane filtration；
4iii) by step 4i) and supernatant mixing 4ii), dense using the purification ultrafiltration system for 10KD for the molecular cut off
Contracting, obtains final product Stem Cell Activity factor concentrated solution；
(5) lyophilization：
5i) in step (4) gained Stem Cell Activity factor concentrated solution, add freeze drying protectant, be dispensed in cillin bottle,
Partly jump a queue, put in freezer dryer；
5ii) open freezer dryer, by predetermined lyophilization program, sample is carried out with lyophilization, tamponade seals, and obtains final product
Freeze dried powder.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, wherein in step (2)
Described Digestive system is 0.25% pancreatin.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, wherein in step (3)
Described flow cytometer detection mark is：CD73, CD90, CD105 expression is positive, and HLA-DR, CD11b, CD19, CD34, CD45 express
Negative
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, wherein in step (3)
Show in described flow cytometer detection marker result that cell has into fat, skeletonization, becomes cartilage differentiation potential.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, wherein step (4) it
In 4i) cell culture to the most vigorous when refer to cell fusion degree about 70-80%.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, wherein step (4) it
When adopting Ultrasonic Cell Disruptor smudge cellses in 4ii), its program is：4 DEG C, 500w, ultrasonic 2 seconds, it is spaced 8 seconds, 86 circulations.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, wherein step (5) it
Freeze drying protectant described in 5i) is selected from trehalose, Mannitol, shitosan, dextran, glycine, arginine, glycine.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, wherein step (5) it
Concentration in described concentrated solution for the freeze drying protectant described in 5i) is 0.5%～10%, particularly 1%～6%.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, wherein step (5) it
Subpackage described in 5i) is with the amount that 3ml/ props up, described Stem Cell Activity factor concentrated solution to be added in described cillin bottle.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, wherein step (5) it
Lyophilization program described in 5ii) includes following operation sequence：
Precooling：Precooling 3.5h (precooling temperature is usually -30～-40 DEG C) at ambient pressure；
Lyophilization a：Opening vacuum pump and making vacuum degree is 0.014mbar, freezes 2h at a temperature of -38～-40 DEG C；
Lyophilization b：Maintain vacuum constant, be warming up to -20～-25 DEG C, continue lyophilization 12h with this understanding；
Then it is warming up to -2～2 DEG C, continue with this understanding 2h is dried；
Parsing-desiccation：Maintain vacuum constant, be warming up to 33～37 DEG C, continue with this understanding 2-5h is dried.
The Stem Cell Activity factor freeze dried powder of any embodiment according to a second aspect of the present invention, it also enters in the preparation
One step includes step 6), that is, to step (4) gained Stem Cell Activity factor concentrated solution or step (5) gained Stem Cell Activity because
Sub- freeze dried powder carries out the operation of Stem Cell Activity factors check, specific as follows：
Take Stem Cell Activity factor concentrated solution 3ml, or lyophilizing front volume is the Stem Cell Activity factor freeze dried powder of 3ml
With 3ml solvent (solvent can be ultra-pure water or hyaluronic acid solution) dilution, using the restructuring coated enzyme linked immunological of personnel's antibody
Test kit (for example, the present invention also adopts, the commercial kit that R＆D company provides) measures the content of the Stem Cell Activity factor.
It has been found that when in step 4ii of the present invention) in 10ml normal saline/T225 culture is added using cell starvation method
During bottle continues culture 12-24 hour, in described normal saline during the sodium citrate of interpolation 0.1～0.2mmol/L concentration
(this sodium citrate can be incorporated into ultrafiltration concentration step below), in step 4iii) in be concentrated by ultrafiltration after, measure concentrated solution
Middle active factorses content (is represented with four kinds of typical activity factors EGF, FGF, VEGF, IL-6 total amount, similarly hereinafter；Represented with C1) and lose
Abandon active factorses content (representing with C2) in liquid, be calculated as follows abandonment percent：Abandonment percent=(C2 ÷ C1) ×
100%.This abandons, and percent is lower to represent that active factorses loss amount is less.Result shows, below present invention preparation stem cell
In each embodiment of active factorses concentrated solution, when adding the sodium citrate of 0.1～0.2mmol/L concentration in above-mentioned steps,
Abandon percent and be respectively less than 1.7%, all in the range of 1.1～1.7%；And abandon percent when without sodium citrate and reach 6
～9%；For example, in embodiment 1 abandon percent be 7.6%, but step 4ii of embodiment 1) 10ml normal saline in add
Plus 0.15mmol/L concentration sodium citrate when abandon percent be 1.2%.But in the test supplementing, the present inventor is shone
CN105543313A201511016742.4) description [0037]～[0045] methods described prepares active factorses concentrated solution, with
When measure concentrated solution and abandon above-mentioned four kinds of typical activity factors EGF, FGF, VEGF, IL-6 total amount calculate abandonment percentage in liquid
Number, it is 13.4% that result abandons percent
Arbitrary technical characteristic that any embodiment of either side of the present invention or this either side has is equally applicable
Other any embodiment or any embodiment of other either side, as long as they will not be conflicting, certainly mutual
Between where applicable, if necessary can individual features be made suitably modify.Make into one with feature to various aspects of the present invention below
The description of step.
All documents recited in the present invention, their full content is incorporated herein by, and if these are civilian
When implication expressed by offering is inconsistent with the present invention, it is defined by the statement of the present invention.Additionally, the present invention use various terms and
Phrase has well known to a person skilled in the art general sense, nonetheless, the present invention remain desirable at this to these terms and
Phrase is described in more detail and explains, the term referring to and phrase if any inconsistent with common art-recognized meanings, with institute of the present invention table
The implication stated is defined.
The gained Stem Cell Activity factor of the present invention or its freeze dried powder, (solvent can be ultrapure to solvent of can directly arranging in pairs or groups
Water or hyaluronic acid solution), can be directly used for beauty and skin care aspect, including beauty treatment, speckle dispelling, repair cicatrix etc.；Or, the present invention
The gained Stem Cell Activity factor or its freeze dried powder, can be directly appended to use in the beauty skin care product of various preparations；Or
Person, the gained Stem Cell Activity factor of the present invention or its freeze dried powder, can use directly as injection, or as facial cream, breast
Liquid, aqueous or common various preparations use.
The inventive method has the advantages that：
1st, cell derived has homogeneity, meets the biological characteristicses of stem cell, thus ensure that stem cell source activity
The secretory volume of the factor, and stability；
2nd, culture medium does not contain allergen, such as antibiotic, hyclone, is suitable for various crowds and uses (especially to blue or green strepto-
Plain allergic human population).
3rd, freeze-dried powder preparation is easy to long-distance transport and long-term preservation.
Brief description
Fig. 1：P0 is for cytological map (× 4)
Fig. 2：P5 is for cytological map (× 10)
Fig. 3：P5 is for cell streaming marker detection result.
Fig. 4：P5 detects for stem cell differentiation potential, and in figure shows matched group, becomes cartilage group, becomes fatty group, skeletonization group
Testing result.
Specific embodiment
The present invention can be conducted further description by the following examples, however, the scope of the present invention does not limit
In following embodiments.One of skill in the art is it is understood that on the premise of without departing substantially from the spirit and scope of the present invention, permissible
Various change and modification are carried out to the present invention.The present invention to test used in material and test method carry out generality
And/or specifically describe.Although for realize many materials that the object of the invention used and operational approach be it is known in the art that
But the present invention still here describes in detail as far as possible.
Embodiment 1：Prepare Stem Cell Activity factor concentrated solution
(1) Mesenchymal Stem Cells from Umbilical Cord obtains：
Take health full term Cesarean esction anemia of pregnant woman's umbilical cord, by separating magnificent Tong Shi glue (Wharton's Jelly) method, logical using China
Prepared by family name's colloidal suspension method；Magnificent Tong Shi glue is put in T75 culture bottle, adds appropriate mescenchymal stem cell (MSC) serum-free medium,
It is placed in 37 DEG C, culture in 5% CO2 incubator, cell colony in 7 days later in culture；Cell reaches saturation within about 12 days, can enter
Row passes on；Cell is in spindle shape, is typical fibroblast sample form (for example, see Fig. 1)；
(2) cell amplification：
When cell fusion degree reaches 70-80%, gently rinse culture bottle cell 1-2 time with normal saline, add 4ml digestion
Liquid (0.25% pancreatin), room temperature places 1-2 minute, Microscopic observation cell subglobular, gently pats bottle wall, stops digestion, turns
Move to centrifuge tube to mix, sampling counts, according to 8000 cell/cm2Passed on, when cell density reaches 70-80% within 2-3 days,
Repeatedly above operate, to obtain the MSC of q.s, typically prepare for cell using P3-P5 that (this example uses P5 for cell, and it shows
Micro- photo is for example, see Fig. 2)；
(3) cellular identification detection：
When Cell viability reaches more than 90%, flow cytometer detection mark is qualified, and standard is：CD73, CD90, CD105 expression sun
Property, HLA-DR, CD11b, CD19, CD34, CD45 expression negative (for example, see Fig. 3), and show in result cell have into fat,
Skeletonization, one-tenth cartilage differentiation potential (for example, see Fig. 4)；
(4) preparation of the Stem Cell Activity factor：
4i) cell culture to the most vigorous when (cell fusion degree about 70-80%), collect supernatant to centrifuge tube, 0.22 μm
Membrane filtration supernatant is degerming；
4ii) clean 2-3 culture bottle with normal saline, discard, then adopt cell starvation method to add 10ml physiology salt
Water/T225 culture bottle continues culture 18 hours, treats cell rounding, and piping and druming moves to centrifuge tube after mixing, and is broken using Ultrasonic Cell Disruptor
(its program is for broken cell：4 DEG C, 500w, ultrasonic 2 seconds, be spaced 8 seconds, 86 circulations) it is centrifuged 1400rpm afterwards, it is centrifuged 5min, collect
Supernatant, degerming through 0.22 μm of membrane filtration；
4iii) by step 4i) and supernatant mixing 4ii), dense using the purification ultrafiltration system for 10KD for the molecular cut off
Contracting, obtains final product Stem Cell Activity factor concentrated solution.
Measure active factorses：Take Stem Cell Activity factor concentrated solution 3ml, using the coated enzyme linked immunological of recombinant human antibody
Test kit (confession of R＆D company) measures the Stem Cell Activity factor (determining four kinds of typical activity factors EGF, FGF, VEGF, IL-6)
Content, using the total amount of above-mentioned four kinds of typical activity factors as the gross activity factor content of concentrated solution.In addition, being measured in the same method step
Rapid 4iii) gained abandons the gross activity factor content in liquid.
In addition, calculating four kinds of typical activity factors EGF, FGF, response rate of VEGF, IL-6 respectively, result shows, this
In bright (embodiment 1～embodiment 3) method, the response rate of EGF, FGF, VEGF, IL-6 is respectively greater than 92.2%, is more than
94.1%th, 91.6%, 92.7%, show that the inventive method has the excellent active factorses response rate.CN105543313A
(201511016742.4), when description [0037]～[0060] methods described prepares active factorses, the response rate recording IL-6 is little
In 87%.
Embodiment 2：Prepare Stem Cell Activity factor concentrated solution
(1) Mesenchymal Stem Cells from Umbilical Cord obtains：
Take health full term Cesarean esction anemia of pregnant woman's umbilical cord, by separating magnificent Tong Shi glue (Wharton's Jelly) method, logical using China
Prepared by family name's colloidal suspension method；Magnificent Tong Shi glue is put in T75 culture bottle, adds appropriate mescenchymal stem cell (MSC) serum-free medium,
It is placed in 37 DEG C, culture in 5% CO2 incubator, cell colony in 7 days later in culture；Cell reaches saturation within about 10 days, can enter
Row passes on；Cell is in spindle shape, is typical fibroblast sample form；
(2) cell amplification：
When cell fusion degree reaches 70-80%, gently rinse culture bottle cell 1-2 time with normal saline, add 5ml digestion
Liquid (0.25% pancreatin), room temperature places 1-2 minute, Microscopic observation cell subglobular, gently pats bottle wall, stops digestion, turns
Move to centrifuge tube to mix, sampling counts, according to 8000 cell/cm2Passed on, when cell density reaches 70-80% within 2-3 days,
Above operation repeatedly, to obtain the MSC of q.s, typically adopts P4 to prepare for cell；
(3) cellular identification detection：
When Cell viability reaches more than 90%, flow cytometer detection mark is qualified, and standard is：CD73, CD90, CD105 expression sun
Property, HLA-DR, CD11b, CD19, CD34, CD45 expression is negative, and shows in result that cell has into fat, skeletonization, becomes cartilage to divide
Change potential；
(4) preparation of the Stem Cell Activity factor：
4i) cell culture to the most vigorous when (cell fusion degree about 70-80%), collect supernatant to centrifuge tube, 0.22 μm
Membrane filtration supernatant is degerming；
4ii) clean 2-3 culture bottle with normal saline, discard, then adopt cell starvation method to add 10ml physiology salt
Water/T225 culture bottle continues culture 12 hours, treats cell rounding, and piping and druming moves to centrifuge tube after mixing, and is broken using Ultrasonic Cell Disruptor
(its program is for broken cell：4 DEG C, 500w, ultrasonic 2 seconds, be spaced 8 seconds, 86 circulations) it is centrifuged 1400rpm afterwards, it is centrifuged 5min, collect
Supernatant, degerming through 0.22 μm of membrane filtration；
4iii) by step 4i) and supernatant mixing 4ii), dense using the purification ultrafiltration system for 10KD for the molecular cut off
Contracting, obtains final product Stem Cell Activity factor concentrated solution.
Measure active factorses：Take Stem Cell Activity factor concentrated solution 3ml, using the coated enzyme linked immunological of recombinant human antibody
Test kit (confession of R＆D company) measures the Stem Cell Activity factor (determining four kinds of typical activity factors EGF, FGF, VEGF, IL-6)
Content, using the total amount of above-mentioned four kinds of typical activity factors as the gross activity factor content of concentrated solution.In addition, being measured in the same method step
Rapid 4iii) gained abandons the gross activity factor content in liquid.
Embodiment 3：Prepare Stem Cell Activity factor concentrated solution
(1) Mesenchymal Stem Cells from Umbilical Cord obtains：
Take health full term Cesarean esction anemia of pregnant woman's umbilical cord, by separating magnificent Tong Shi glue (Wharton's Jelly) method, logical using China
Prepared by family name's colloidal suspension method；Magnificent Tong Shi glue is put in T75 culture bottle, adds appropriate mescenchymal stem cell (MSC) serum-free medium,
It is placed in 37 DEG C, culture in 5% CO2 incubator, cell colony in 7 days later in culture；Cell reaches saturation within about 13 days, can enter
Row passes on；Cell is in spindle shape, is typical fibroblast sample form；
(2) cell amplification：
When cell fusion degree reaches 70-80%, gently rinse culture bottle cell 1-2 time with normal saline, add 3ml digestion
Liquid (0.25% pancreatin), room temperature places 1-2 minute, Microscopic observation cell subglobular, gently pats bottle wall, stops digestion, turns
Move to centrifuge tube to mix, sampling counts, according to 8000 cell/cm2Passed on, when cell density reaches 70-80% within 2-3 days,
Above operation repeatedly, to obtain the MSC of q.s, typically adopts P3 to prepare for cell；
(3) cellular identification detection：
When Cell viability reaches more than 90%, flow cytometer detection mark is qualified, and standard is：CD73, CD90, CD105 expression sun
Property, HLA-DR, CD11b, CD19, CD34, CD45 expression is negative, and shows in result that cell has into fat, skeletonization, becomes cartilage to divide
Change potential；
(4) preparation of the Stem Cell Activity factor：
4i) cell culture to the most vigorous when (cell fusion degree about 70-80%), collect supernatant to centrifuge tube, 0.22 μm
Membrane filtration supernatant is degerming；
4ii) clean 2-3 culture bottle with normal saline, discard, then adopt cell starvation method to add 10ml physiology salt
Water/T225 culture bottle continues culture 24 hours, treats cell rounding, and piping and druming moves to centrifuge tube after mixing, and is broken using Ultrasonic Cell Disruptor
(its program is for broken cell：4 DEG C, 500w, ultrasonic 2 seconds, be spaced 8 seconds, 86 circulations) it is centrifuged 1400rpm afterwards, it is centrifuged 5min, collect
Supernatant, degerming through 0.22 μm of membrane filtration；
4iii) by step 4i) and supernatant mixing 4ii), dense using the purification ultrafiltration system for 10KD for the molecular cut off
Contracting, obtains final product Stem Cell Activity factor concentrated solution.
Measure active factorses：Take Stem Cell Activity factor concentrated solution 3ml, using the coated enzyme linked immunological of recombinant human antibody
Test kit (confession of R＆D company) measures the Stem Cell Activity factor (determining four kinds of typical activity factors EGF, FGF, VEGF, IL-6)
Content, using the total amount of above-mentioned four kinds of typical activity factors as the gross activity factor content of concentrated solution.In addition, being measured in the same method step
Rapid 4iii) gained abandons the gross activity factor content in liquid.
Lyophilized powder example 1：Prepare Stem Cell Activity factor freeze dried powder
5i) take step embodiment 1 gained Stem Cell Activity factor concentrated solution, be added to freeze drying protectant (trehalose)
And dissolve, and the concentration after making freeze drying protectant dissolve wherein reaches 4%, is dispensed in cillin bottle (3ml/ props up), partly jumps a queue, puts
In freezer dryer；
5ii) open freezer dryer, by predetermined lyophilization program, sample is carried out with lyophilization, tamponade seals, and obtains final product
Freeze dried powder；Lyophilization program is as follows：
Precooling：Precooling 3.5h (precooling temperature is -35 DEG C) at ambient pressure；
Lyophilization a：Opening vacuum pump and making vacuum degree is 0.014mbar, freezes 2h at a temperature of -38～-40 DEG C；
Lyophilization b：Maintain vacuum constant, be warming up to -23 DEG C, continue lyophilization 12h with this understanding；Then rise
Temperature, to -2～2 DEG C, continues 2h is dried with this understanding；
Parsing-desiccation：Maintain vacuum constant, be warming up to 35 DEG C, continue with this understanding 4h is dried.
Measure the active factorses of freeze dried powder：
Stem Cell Activity factor freeze dried powder is taken (to be approximately equivalent to the amount of concentrated solution 3ml before lyophilization, using restructuring in right amount
The coated enzyme linked immunological kit of human antibody (confession of R＆D company) measures the Stem Cell Activity factor and (determines four kinds of typical activity
Factor EGF, FGF, VEGF, IL-6) content, using the total amount of above-mentioned four kinds of typical activity factors as the gross activity of concentrated solution because
Sub- content.Relatively it is closer to respect to the gross activity factor content percent before lyophilization, this percent after lyophilization
100% better.Result shows, whole freeze dried powders of lyophilized powder example 1 to lyophilized powder example 5, its gross activity factor content percentage
Number, all in the range of 98～101%, shows that lyophilized powder of the present invention has excellent property, lives during preparation lyophilization powder
Sex factor does not lose.
Lyophilized powder example 2：Prepare Stem Cell Activity factor freeze dried powder
5i) take step embodiment 2 gained Stem Cell Activity factor concentrated solution, be added to freeze drying protectant (Mannitol)
And dissolve, and the concentration after making freeze drying protectant dissolve wherein reaches 1%, is dispensed in cillin bottle (3ml/ props up), partly jumps a queue, puts
In freezer dryer；
5ii) open freezer dryer, by predetermined lyophilization program, sample is carried out with lyophilization, tamponade seals, and obtains final product
Freeze dried powder；Lyophilization program is as follows：
Precooling：Precooling 3.5h (precooling temperature is -40 DEG C) at ambient pressure；
Lyophilization a：Opening vacuum pump and making vacuum degree is 0.014mbar, freezes 2h at a temperature of -38～-40 DEG C；
Lyophilization b：Maintain vacuum constant, be warming up to -20 DEG C, continue lyophilization 12h with this understanding；Then rise
Temperature, to -2～2 DEG C, continues 2h is dried with this understanding；
Parsing-desiccation：Maintain vacuum constant, be warming up to 37 DEG C, continue with this understanding 2h is dried.
Lyophilized powder example 3：Prepare Stem Cell Activity factor freeze dried powder
5i) take step embodiment 3 gained Stem Cell Activity factor concentrated solution, be added to freeze drying protectant (shitosan)
And dissolve, and the concentration after making freeze drying protectant dissolve wherein reaches 6%, is dispensed in cillin bottle (3ml/ props up), partly jumps a queue, puts
In freezer dryer；
5ii) open freezer dryer, by predetermined lyophilization program, sample is carried out with lyophilization, tamponade seals, and obtains final product
Freeze dried powder；Lyophilization program is as follows：
Precooling：Precooling 3.5h (precooling temperature is -30 DEG C) at ambient pressure；
Lyophilization a：Opening vacuum pump and making vacuum degree is 0.014mbar, freezes 2h at a temperature of -38～-40 DEG C；
Lyophilization b：Maintain vacuum constant, be warming up to -25 DEG C, continue lyophilization 12h with this understanding；Then rise
Temperature, to -2～2 DEG C, continues 2h is dried with this understanding；
Parsing-desiccation：Maintain vacuum constant, be warming up to 33 DEG C, continue with this understanding 5h is dried.
Lyophilized powder example 4：Prepare Stem Cell Activity factor freeze dried powder
5i) take step embodiment 1,2,3 gained Stem Cell Activity factor concentrated solution respectively, be added to freeze drying protectant
(dextran) simultaneously dissolves, and the concentration after making freeze drying protectant dissolve wherein reaches 4%, is dispensed into (3ml/ in cillin bottle
), partly jump a queue, put in freezer dryer；
5ii) open freezer dryer, by predetermined lyophilization program, sample is carried out with lyophilization, tamponade seals, and obtains final product
Freeze dried powder；Lyophilization program is as follows：
Precooling：Precooling 3.5h (precooling temperature is -35 DEG C) at ambient pressure；
Lyophilization a：Opening vacuum pump and making vacuum degree is 0.014mbar, freezes 2h at a temperature of -38～-40 DEG C；
Lyophilization b：Maintain vacuum constant, be warming up to -25 DEG C, continue lyophilization 12h with this understanding；Then rise
Temperature, to -2～2 DEG C, continues 2h is dried with this understanding；
Parsing-desiccation：Maintain vacuum constant, be warming up to 35 DEG C, continue with this understanding 3h is dried.
Lyophilized powder example 5：Prepare Stem Cell Activity factor freeze dried powder
5i) take step embodiment 1,2,3 gained Stem Cell Activity factor concentrated solution respectively, be added to freeze drying protectant
(glycine) simultaneously dissolves, and the concentration after making freeze drying protectant dissolve wherein reaches 3%, is dispensed in cillin bottle (3ml/ props up),
Partly jump a queue, put in freezer dryer；
5ii) open freezer dryer, by predetermined lyophilization program, sample is carried out with lyophilization, tamponade seals, and obtains final product
Freeze dried powder；Lyophilization program is as follows：
Precooling：Precooling 3.5h (precooling temperature is -37 DEG C) at ambient pressure；
Lyophilization a：Opening vacuum pump and making vacuum degree is 0.014mbar, freezes 2h at a temperature of -38～-40 DEG C；
Lyophilization b：Maintain vacuum constant, be warming up to -25 DEG C, continue lyophilization 12h with this understanding；Then rise
Temperature, to -2～2 DEG C, continues 2h is dried with this understanding；
Parsing-desiccation：Maintain vacuum constant, be warming up to 35 DEG C, continue with this understanding 4h is dried.
Claims (10)
1. the method preparing the Stem Cell Activity factor, it comprises the following steps：
(1) Mesenchymal Stem Cells from Umbilical Cord obtains：
Take health full term Cesarean esction anemia of pregnant woman's umbilical cord, by separating magnificent Tong Shi glue (Wharton's Jelly) method, using magnificent Tong Shi glue
Prepared by suspension method；Magnificent Tong Shi glue is put in T75 culture bottle, adds appropriate mescenchymal stem cell (MSC) serum-free medium, be placed in
37 DEG C, culture in 5% CO2 incubator, cell colony in 7 days later in culture；Cell reaches saturation within about 10-13 days, can enter
Row passes on；Cell is in spindle shape, is typical fibroblast sample form；
(2) cell amplification：
When cell fusion degree reaches 70-80%, gently rinse culture bottle cell 1-2 time with normal saline, add 3-5ml digestion
Liquid, room temperature places 1-2 minute, Microscopic observation cell subglobular, gently pats bottle wall, stops digestion, is transferred to centrifuge tube and mixes
Even, sampling counts, according to 8000 cell/cm2Passed on, when cell density reaches 70-80% within 2-3 days, above operation repeatedly,
To obtain the MSC of q.s, P3-P5 is typically adopted to prepare for cell；
(3) cellular identification detection：
When Cell viability reaches more than 90%, flow cytometer detection mark is qualified；
(4) preparation of the Stem Cell Activity factor：
4i) cell culture to the most vigorous when, collect supernatant to centrifuge tube, 0.22 μm of membrane filtration supernatant is degerming；
4ii) clean 2-3 culture bottle with normal saline, discard, then adopt cell starvation method add 10ml normal saline/
T225 culture bottle continues culture 12-24 hour, treats cell rounding, and piping and druming moves to centrifuge tube after mixing, and is broken using Ultrasonic Cell Disruptor
Centrifugation 1400rpm after broken cell, centrifugation 5min, the supernatant of collection, degerming through 0.22 μm of membrane filtration；
4iii) by step 4i) and supernatant mixing 4ii), concentrated using the purification ultrafiltration system for 10KD for the molecular cut off, that is,
Obtain Stem Cell Activity factor concentrated solution.
2. method according to claim 1, wherein：
Described in step (2), Digestive system is 0.25% pancreatin；
Described in step (3), flow cytometer detection mark is：CD73, CD90, CD105 expression is positive, HLA-DR, CD11b, CD19,
CD34, CD45 expression is negative；
Show in flow cytometer detection marker result described in step (3) that cell has into fat, skeletonization, becomes cartilage differentiation potential；
The 4i of step (4)) in cell culture to the most vigorous when refer to cell fusion degree about 70-80%；
The 4ii of step (4)) in using Ultrasonic Cell Disruptor smudge cellses when, its program is：4 DEG C, 500w, ultrasonic 2 seconds, it is spaced 8
Second, 86 circulations.
3. method according to claim 1, it still further comprises step (5), that is, to step (4) the gained Stem Cell Activity factor
Carry out cryodesiccated step.
4. method according to claim 3, wherein said the Stem Cell Activity factor is carried out cryodesiccated step include as follows
Operation：
5i) in step (4) gained Stem Cell Activity factor concentrated solution, add freeze drying protectant, be dispensed in cillin bottle, half adds
Plug, puts in freezer dryer；
5ii) open freezer dryer, by predetermined lyophilization program, sample is carried out with lyophilization, tamponade seals, and obtains final product lyophilizing
Powder.
5. method according to claim 4, wherein：
The 5i of step (5)) described in freeze drying protectant be selected from trehalose, Mannitol, shitosan, dextran, glycine, smart ammonia
Acid, glycine；
The 5i of step (5)) described in concentration in described concentrated solution for the freeze drying protectant be 0.5%～10%, particularly 1%～
6%；
The 5i of step (5)) described in subpackage to be that described Stem Cell Activity factor concentrated solution is added to by the amount propped up with 3ml/ described
In cillin bottle；
The 5ii of step (5)) described in lyophilization program include following operation sequence：
Precooling：Precooling 3.5h (precooling temperature is usually -30～-40 DEG C) at ambient pressure；
Lyophilization a：Opening vacuum pump and making vacuum degree is 0.014mbar, freezes 2h at a temperature of -38～-40 DEG C；
Lyophilization b：Maintain vacuum constant, be warming up to -20～-25 DEG C, continue lyophilization 12h with this understanding；Then
It is warming up to -2～2 DEG C, continue with this understanding 2h is dried；
Parsing-desiccation：Maintain vacuum constant, be warming up to 33～37 DEG C, continue with this understanding 2-5h is dried.
6. method according to claim 1, it still further comprises step (6), that is, to step (4) the gained Stem Cell Activity factor
Concentrated solution or step (5) gained Stem Cell Activity factor freeze dried powder carry out the operation of Stem Cell Activity factors check, specifically
As follows：
Take Stem Cell Activity factor concentrated solution 3ml, or the Stem Cell Activity factor freeze dried powder that lyophilizing front volume is 3ml is used
3ml solvent (solvent can be ultra-pure water or hyaluronic acid solution) dilutes, using restructuring personnel's antibody coated enzyme linked immunological examination
Agent box (for example, the present invention also adopts, the commercial kit that R＆D company provides) measures the content of the Stem Cell Activity factor.
7. a kind of Stem Cell Activity factor freeze dried powder, including the Stem Cell Activity factor and freeze drying protectant.
8. Stem Cell Activity factor freeze dried powder according to claim 7, wherein：
Described freeze drying protectant is selected from trehalose, Mannitol, shitosan, dextran, glycine, arginine, glycine；
It substantially prepares according to the method comprising the steps：
(1) Mesenchymal Stem Cells from Umbilical Cord obtains：
Take health full term Cesarean esction anemia of pregnant woman's umbilical cord, by separating magnificent Tong Shi glue (Wharton's Jelly) method, using magnificent Tong Shi glue
Prepared by suspension method；Magnificent Tong Shi glue is put in T75 culture bottle, adds appropriate mescenchymal stem cell (MSC) serum-free medium, be placed in
37 DEG C, culture in 5% CO2 incubator, cell colony in 7 days later in culture；Cell reaches saturation within about 10-13 days, can enter
Row passes on；Cell is in spindle shape, is typical fibroblast sample form；
(2) cell amplification：
When cell fusion degree reaches 70-80%, gently rinse culture bottle cell 1-2 time with normal saline, add 3-5ml digestion
Liquid, room temperature places 1-2 minute, Microscopic observation cell subglobular, gently pats bottle wall, stops digestion, is transferred to centrifuge tube and mixes
Even, sampling counts, according to 8000 cell/cm2Passed on, when cell density reaches 70-80% within 2-3 days, above operation repeatedly,
To obtain the MSC of q.s, P3-P5 is typically adopted to prepare for cell；
(3) cellular identification detection：
When Cell viability reaches more than 90%, flow cytometer detection mark is qualified；
(4) preparation of the Stem Cell Activity factor：
4i) cell culture to the most vigorous when, collect supernatant to centrifuge tube, 0.22 μm of membrane filtration supernatant is degerming；
4ii) clean 2-3 culture bottle with normal saline, discard, then adopt cell starvation method add 10ml normal saline/
T225 culture bottle continues culture 12-24 hour, treats cell rounding, and piping and druming moves to centrifuge tube after mixing, and is broken using Ultrasonic Cell Disruptor
Centrifugation 1400rpm after broken cell, centrifugation 5min, the supernatant of collection, degerming through 0.22 μm of membrane filtration；
4iii) by step 4i) and supernatant mixing 4ii), concentrated using the purification ultrafiltration system for 10KD for the molecular cut off, that is,
Obtain Stem Cell Activity factor concentrated solution；
(5) lyophilization：
5i) in step (4) gained Stem Cell Activity factor concentrated solution, add freeze drying protectant, be dispensed in cillin bottle, half adds
Plug, puts in freezer dryer；
5ii) open freezer dryer, by predetermined lyophilization program, sample is carried out with lyophilization, tamponade seals, and obtains final product lyophilizing
Powder.
9. Stem Cell Activity factor freeze dried powder according to claim 8, wherein：
Described in step (2), Digestive system is 0.25% pancreatin；
Described in step (3), flow cytometer detection mark is：CD73, CD90, CD105 expression is positive, HLA-DR, CD11b, CD19,
CD34, CD45 expression is negative；
Show in flow cytometer detection marker result described in step (3) that cell has into fat, skeletonization, becomes cartilage differentiation potential；
The 4i of step (4)) in cell culture to the most vigorous when refer to cell fusion degree about 70-80%；
The 4ii of step (4)) in using Ultrasonic Cell Disruptor smudge cellses when, its program is：4 DEG C, 500w, ultrasonic 2 seconds, it is spaced 8
Second, 86 circulations；
The 5i of step (5)) described in freeze drying protectant be selected from trehalose, Mannitol, shitosan, dextran, glycine, smart ammonia
Acid, glycine；
The 5i of step (5)) described in concentration in described concentrated solution for the freeze drying protectant be 0.5%～10%, particularly 1%～
6%；
The 5i of step (5)) described in subpackage to be that described Stem Cell Activity factor concentrated solution is added to by the amount propped up with 3ml/ described
In cillin bottle.
10. Stem Cell Activity factor freeze dried powder according to claim 8, wherein
The 5ii of step (5)) described in lyophilization program include following operation sequence：
Precooling：Precooling 3.5h (precooling temperature is usually -30～-40 DEG C) at ambient pressure；
Lyophilization a：Opening vacuum pump and making vacuum degree is 0.014mbar, freezes 2h at a temperature of -38～-40 DEG C；
Lyophilization b：Maintain vacuum constant, be warming up to -20～-25 DEG C, continue lyophilization 12h with this understanding；Then
It is warming up to -2～2 DEG C, continue with this understanding 2h is dried；
Parsing-desiccation：Maintain vacuum constant, be warming up to 33～37 DEG C, continue with this understanding 2-5h is dried.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610819087.4A CN106381284B (en) | 2016-09-12 | 2016-09-12 | Method for preparing stem cell active factor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610819087.4A CN106381284B (en) | 2016-09-12 | 2016-09-12 | Method for preparing stem cell active factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106381284A true CN106381284A (en) | 2017-02-08 |
| CN106381284B CN106381284B (en) | 2020-06-23 |
Family
ID=57936424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610819087.4A Active CN106381284B (en) | 2016-09-12 | 2016-09-12 | Method for preparing stem cell active factor |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106381284B (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106880645A (en) * | 2017-02-28 | 2017-06-23 | 天津普瑞赛尔生物科技有限公司 | Enema liquid containing mescenchymal stem cell secretion for small household pet and preparation method thereof |
| CN106963781A (en) * | 2017-05-17 | 2017-07-21 | 天津普瑞赛尔生物科技有限公司 | Reparation parenteral solution of the secretion of human mesenchymal stem cell containing high concentration for small-sized pet and preparation method thereof |
| CN107174590A (en) * | 2017-05-17 | 2017-09-19 | 天津普瑞赛尔生物科技有限公司 | For small-sized pet containing reparation spray of people's mesenchymal stem cells extract and preparation method thereof between high concentration |
| CN107184604A (en) * | 2017-05-17 | 2017-09-22 | 天津普瑞赛尔生物科技有限公司 | A kind of high concentration human mesenchymal stem cell extract and preparation method thereof |
| CN107412266A (en) * | 2017-05-17 | 2017-12-01 | 天津普瑞赛尔生物科技有限公司 | Small-sized pet eye drops of the secretion containing human mesenchymal stem cell and preparation method thereof |
| CN108186682A (en) * | 2018-02-01 | 2018-06-22 | 伯仕利生物科技发展（盐城）有限公司 | A kind of preparation method of placenta mesenchyma stem cell freeze-dried powder |
| CN108823156A (en) * | 2018-07-04 | 2018-11-16 | 陕西神州生物技术有限公司 | For the clinical grade human umbilical cord mesenchymal stem cells composite factor of reparation and the preparation method of freeze-dried powder |
| CN108865990A (en) * | 2018-07-25 | 2018-11-23 | 广州赛莱拉干细胞科技股份有限公司 | A kind of biological agent and preparation method thereof for skin injury reparation |
| CN109097391A (en) * | 2018-07-11 | 2018-12-28 | 个体化细胞治疗技术国家地方联合工程实验室（深圳） | A kind of method and its application that decidua mescenchymal stem cell active factors are mass produced |
| CN110499287A (en) * | 2019-08-30 | 2019-11-26 | 博雅干细胞科技有限公司 | The method for simply preparing placenta mesenchyma stem cell excretion body |
| CN110540956A (en) * | 2019-08-30 | 2019-12-06 | 博雅干细胞科技有限公司 | method for simply preparing cell factor from placenta mesenchymal stem cells |
| CN110804607A (en) * | 2019-11-18 | 2020-02-18 | 深圳市润科生物科技有限公司 | Preparation method of high-concentration human mesenchymal stem cell lysate |
| CN111557896A (en) * | 2020-06-23 | 2020-08-21 | 华悦汇(上海)健康科技有限公司 | Preparation method of cell factor for hair follicle activation function |
| WO2020173164A1 (en) * | 2019-02-28 | 2020-09-03 | 京东方科技集团股份有限公司 | Lyophilized powder of mesenchymal stem cell and preparation method therefor |
| WO2021077812A1 (en) * | 2019-10-21 | 2021-04-29 | 江苏艾洛特医药研究院有限公司 | Umbilical cord mesenchymal stem cell factor freeze-dried powder, preparation method therefor and application thereof |
| CN113583950A (en) * | 2021-08-06 | 2021-11-02 | 合肥滴碧云生物科技有限公司 | Method for preparing stem cell active factor and application thereof |
| CN115006711A (en) * | 2022-06-23 | 2022-09-06 | 广东瑞程医学科技有限公司 | Microneedle loaded with active self-regeneration factor and preparation method and application thereof |
| CN115786258A (en) * | 2023-02-01 | 2023-03-14 | 昆明时光肌生物技术有限公司 | Preparation method of cell culture medium additive |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102586182A (en) * | 2010-12-17 | 2012-07-18 | 张正前 | Preparation and application of human-stem-cell-secreted bioactive factor and lysis solution |
| CN105543313A (en) * | 2015-12-29 | 2016-05-04 | 四川新生命干细胞科技股份有限公司 | Human-derived mesenchymal stem cell factor, and preparation method and application thereof |
-
2016
- 2016-09-12 CN CN201610819087.4A patent/CN106381284B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102586182A (en) * | 2010-12-17 | 2012-07-18 | 张正前 | Preparation and application of human-stem-cell-secreted bioactive factor and lysis solution |
| CN105543313A (en) * | 2015-12-29 | 2016-05-04 | 四川新生命干细胞科技股份有限公司 | Human-derived mesenchymal stem cell factor, and preparation method and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| MAHANANI, ERLINA SIH ET AL: "Human Mesenchymal Stem Cells Behavior on Synthetic Coral Scaffold", 《KEY ENGINEERING MATERIALS》 * |
| 黎佼等: "年青人骨髓间充质干细胞来源生物活性因子对年老人骨髓间充质干细胞功能的影响", 《广东医学》 * |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106880645A (en) * | 2017-02-28 | 2017-06-23 | 天津普瑞赛尔生物科技有限公司 | Enema liquid containing mescenchymal stem cell secretion for small household pet and preparation method thereof |
| CN106963781A (en) * | 2017-05-17 | 2017-07-21 | 天津普瑞赛尔生物科技有限公司 | Reparation parenteral solution of the secretion of human mesenchymal stem cell containing high concentration for small-sized pet and preparation method thereof |
| CN107174590A (en) * | 2017-05-17 | 2017-09-19 | 天津普瑞赛尔生物科技有限公司 | For small-sized pet containing reparation spray of people's mesenchymal stem cells extract and preparation method thereof between high concentration |
| CN107184604A (en) * | 2017-05-17 | 2017-09-22 | 天津普瑞赛尔生物科技有限公司 | A kind of high concentration human mesenchymal stem cell extract and preparation method thereof |
| CN107412266A (en) * | 2017-05-17 | 2017-12-01 | 天津普瑞赛尔生物科技有限公司 | Small-sized pet eye drops of the secretion containing human mesenchymal stem cell and preparation method thereof |
| CN108186682A (en) * | 2018-02-01 | 2018-06-22 | 伯仕利生物科技发展（盐城）有限公司 | A kind of preparation method of placenta mesenchyma stem cell freeze-dried powder |
| CN108823156A (en) * | 2018-07-04 | 2018-11-16 | 陕西神州生物技术有限公司 | For the clinical grade human umbilical cord mesenchymal stem cells composite factor of reparation and the preparation method of freeze-dried powder |
| CN109097391A (en) * | 2018-07-11 | 2018-12-28 | 个体化细胞治疗技术国家地方联合工程实验室（深圳） | A kind of method and its application that decidua mescenchymal stem cell active factors are mass produced |
| CN108865990A (en) * | 2018-07-25 | 2018-11-23 | 广州赛莱拉干细胞科技股份有限公司 | A kind of biological agent and preparation method thereof for skin injury reparation |
| WO2020173164A1 (en) * | 2019-02-28 | 2020-09-03 | 京东方科技集团股份有限公司 | Lyophilized powder of mesenchymal stem cell and preparation method therefor |
| CN110540956A (en) * | 2019-08-30 | 2019-12-06 | 博雅干细胞科技有限公司 | method for simply preparing cell factor from placenta mesenchymal stem cells |
| CN110499287A (en) * | 2019-08-30 | 2019-11-26 | 博雅干细胞科技有限公司 | The method for simply preparing placenta mesenchyma stem cell excretion body |
| CN110499287B (en) * | 2019-08-30 | 2021-07-23 | 博雅干细胞科技有限公司 | Method for simply preparing placenta mesenchymal stem cell exosome |
| WO2021077812A1 (en) * | 2019-10-21 | 2021-04-29 | 江苏艾洛特医药研究院有限公司 | Umbilical cord mesenchymal stem cell factor freeze-dried powder, preparation method therefor and application thereof |
| CN110804607A (en) * | 2019-11-18 | 2020-02-18 | 深圳市润科生物科技有限公司 | Preparation method of high-concentration human mesenchymal stem cell lysate |
| CN110804607B (en) * | 2019-11-18 | 2021-09-21 | 深圳市润科生物科技有限公司 | Preparation method of high-concentration human mesenchymal stem cell lysate |
| CN111557896A (en) * | 2020-06-23 | 2020-08-21 | 华悦汇(上海)健康科技有限公司 | Preparation method of cell factor for hair follicle activation function |
| CN113583950A (en) * | 2021-08-06 | 2021-11-02 | 合肥滴碧云生物科技有限公司 | Method for preparing stem cell active factor and application thereof |
| CN115006711A (en) * | 2022-06-23 | 2022-09-06 | 广东瑞程医学科技有限公司 | Microneedle loaded with active self-regeneration factor and preparation method and application thereof |
| CN115786258A (en) * | 2023-02-01 | 2023-03-14 | 昆明时光肌生物技术有限公司 | Preparation method of cell culture medium additive |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106381284B (en) | 2020-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106381284A (en) | Method for preparing stem cell active factor | |
| CN106344492B (en) | The Stem Cell Activity factor and its freeze dried powder | |
| CN110129265A (en) | A kind of umbilical cord mesenchymal stem cells excretion body, preparation method and the application in cosmetics | |
| EP2368974A1 (en) | Methods for isolating mesenchymal stem cells from embryos of human or animals and extracting secretion substances thereof | |
| CN110269833A (en) | A kind of umbilical cord mesenchymal stem cells preparation and its preparation method and application | |
| CN104673747A (en) | Method for preparing platelet lysate and application of platelet lysate | |
| CN103352026A (en) | Method for cultivating autologous umbilical cord mesenchymal stem cells by adopting human umbilical cord blood rich platelet lysate | |
| CN105238748A (en) | Preparation method of placenta-source decidua parietalis mesenchymal stem cells by separation and refrigeration | |
| CN107034183A (en) | The method for preparing autologous fat stem cell bioactivity peptide freeze-dried powder | |
| CN108753708B (en) | A kind of preparation method of Stem Cell Activity factor freeze-dried powder | |
| JP6711757B2 (en) | Method to differentiate into hepatocytes using pluripotent stem cells derived from mesenchymal stem cells | |
| CN107412119A (en) | The freeze-dried powder prepared from placenta enrichment blood platelet and extraction active factors | |
| CN110946876A (en) | Application of mesenchymal stem cell exosome preparation in treating alopecia areata | |
| WO2020173164A1 (en) | Lyophilized powder of mesenchymal stem cell and preparation method therefor | |
| CN108685948A (en) | A kind of preparation method of new medical cell repair agent | |
| CN106834219A (en) | A kind of extraction of Endometrial stem cell and its method for building stem cell bank | |
| CN106492194A (en) | A kind of stem cell excretion body preparation and its preparation method and application | |
| CN107397710A (en) | A kind of preparation method and applications of skin stem cell active element | |
| CN106801034A (en) | A kind of Endometrial stem cell large-scale preparation method and its application | |
| EP3156481B1 (en) | Method for manufacturing induced pluripotent stem cells from adipose-derived mesenchymal stem cells and induced pluripotent stem cells manufactured by same method | |
| CN109010369A (en) | A kind of preparation method for repairing mammalian gut damage freeze-dried powder | |
| CN107412118A (en) | Blood platelet and the method for extracting active factors are enriched with from placenta | |
| US20230076688A1 (en) | Method for preparing induced pluripotent stem cell line from mesenchymal stem cells, and cell line obtained thereby | |
| WO2024045404A1 (en) | Bone marrow supernatant and use thereof in cell culture | |
| JP6711756B2 (en) | Method for differentiating into adipocytes using pluripotent stem cells derived from mesenchymal stem cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |